Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.064 | 0.7 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |